Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

There comes a point in the life of every brand when exclusivity will be lost and generics will begin to compete for market share. However this is not the end of the brand’s lifecycle and many ...

Global X Robotics & Artificial Intelligence is diversified across capital goods, hardware, and healthcare, reducing valuation ...

The VIX is known as the Fear Gauge because it tracks how much investors are paying for protection against a market decline.

Genpharmasec Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 172.21 Crore ... the company has a total of 55.37 Crore shares outstanding.Generic Pharmasec Share ...

As employers grapple with including GLP-1s in their benefits packages, they face a complex decision that boils down to two ...

Any opinions, news, research, analyses, prices or other information contained on this website, by FXStreet, its employees, clients or contributors, is provided as general market commentary and ...

However, this relies on there being competition in the market. Recently, the media has highlighted a number of instances where, in the absence of competition, the price of an old generic drug has ...

long-term drivers continue to support the price. Every year at this time, we find ourselves having to think twice before writing a date. Gold was one of the best-performing asset classes in 2024, ...

This country research report on Vietnam Atherosclerosis Drugs Market offers comprehensive insights into the market landscape, customer intelligence, and competitive strategies in the Vietnam market.